significant difference in tumor incidence in our study as to patients' gender, although female patients slightly predominated with 50.7%, as in studies. [9][10][11][12] The age of patients in our study ranged from 9 to 84 years (mean 54.1 ± 14.83). There was a statistically significant higher incidence of malignant tumors in older patients. 8,10,13,14 As to tumor localization, the parotid gland is the most commonly affected; our study showed that MSGs were the most common localization (83.56%), and the parotid gland was most commonly affected with 692 cases (76.3% of salivary gland tumors). 1,10 12,14,16 MSG tumors were most commonly benign (87.07%). MiSG sites are the most commonly affected after the parotid gland, followed by the submandibular and sublingual glands. 1,4,[8][9][10][11][12]14,16,18,19 Our study's most common MiSG site was the oral cavity, followed by the nasal cavity and paranasal sinuses; the larynx was the rarest MiSG site.Submandibular gland tumors comprised 7.06% of all salivary tumors in our series. Salivary gland tumors are sporadic in the sublingual gland and are most exclusively malignant. 1,8 Various studies report that the submandibular gland was affected in 17% to 23% and MiSG sites in 14% to 22%. 10,18 MiSG tumors represented 16.4% of salivary glands tumors in our study, whereas other studies do not report MiSG tumors. 8,9,17 Sublingual gland tumors incidence was reported at 0.4% to 3.2%. 14,17 Our study reports 0.20% of salivary tumors in the sublingual gland.Papers from different geographic regions show that most salivary gland tumors are benign, ranging from 64.2% to71.5%, 8,10,19 and of these, the most common is pleomorphic adenoma. The majority of parotid tumors are benign, with pleomorphic adenoma and Warthin tumor being the most common. 1,